Julia Schleypen

612 total citations
11 papers, 483 citations indexed

About

Julia Schleypen is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Julia Schleypen has authored 11 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Molecular Biology. Recurrent topics in Julia Schleypen's work include Monoclonal and Polyclonal Antibodies Research (5 papers), Biosimilars and Bioanalytical Methods (4 papers) and T-cell and B-cell Immunology (4 papers). Julia Schleypen is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (5 papers), Biosimilars and Bioanalytical Methods (4 papers) and T-cell and B-cell Immunology (4 papers). Julia Schleypen collaborates with scholars based in Germany, Switzerland and Denmark. Julia Schleypen's co-authors include Kay Stubenrauch, Uwe Wessels, Christine S. Falk, Heike Pohla, K. Rohrmann, Dolores J. Schendel, Robert Kammerer, Elfriede Noeßner, Francisco C. Ramirez and Roland F. Staack and has published in prestigious journals such as Analytical Biochemistry, Clinical Cancer Research and International Journal of Cancer.

In The Last Decade

Julia Schleypen

10 papers receiving 463 citations

Peers

Julia Schleypen

IMMUN

RNMI

ONCOL

PRM

Patricia Marchal France

Peter Ruschpler Germany

Elisabeth Mertsching United States

Inbal Binsky Israel

Bjarne Bogen Norway

Geoffrey Catalano United States

Jill Stanley United States

Natalie Donin Israel

Lisa Bruns Germany

Emmanuelle Astoul United Kingdom

Patricia Marchal France

Julia Schleypen

179 ×0.6

IMMUN

81 ×0.5

RNMI

89 ×0.5

ONCOL

212 ×1.3

26 ×0.7

PRM

Citations per year, relative to Julia Schleypen Julia Schleypen (= 1×) peers Patricia Marchal

Countries citing papers authored by Julia Schleypen

Since Specialization

Citations

This map shows the geographic impact of Julia Schleypen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Schleypen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Schleypen more than expected).

Fields of papers citing papers by Julia Schleypen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Schleypen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Schleypen. The network helps show where Julia Schleypen may publish in the future.

Co-authorship network of co-authors of Julia Schleypen

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Schleypen. A scholar is included among the top collaborators of Julia Schleypen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Schleypen. Julia Schleypen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Staack, Roland F., et al.. (2011). Quality Requirements for Critical Assay Reagents Used in Bioanalysis of Therapeutic Proteins: What Bioanalysts Should Know About Their Reagents. Bioanalysis. 3(5). 523–534. 54 indexed citations

Stubenrauch, Kay, et al.. (2010). Evaluation of a generic immunoassay with drug tolerance to detect immune complexes in serum samples from cynomolgus monkeys after administration of human antibodies. Journal of Pharmaceutical and Biomedical Analysis. 52(2). 249–254. 38 indexed citations

Stubenrauch, Kay, Uwe Wessels, Herbert Birnboeck, et al.. (2010). Subset analysis of patients experiencing clinical events of a potentially immunogenic nature in the pivotal clinical trials of tocilizumab for rheumatoid arthritis: Evaluation of an antidrug antibody ELISA using clinical adverse event-driven immunogenicity testing. Clinical Therapeutics. 32(9). 1597–1609. 53 indexed citations

Stubenrauch, Kay, Uwe Wessels, Jörg T. Regula, et al.. (2009). Impact of Molecular Processing in the Hinge Region of Therapeutic IgG4 Antibodies on Disposition Profiles in Cynomolgus Monkeys. Drug Metabolism and Disposition. 38(1). 84–91. 37 indexed citations

Stubenrauch, Kay, et al.. (2009). Evaluation of a biosensor immunoassay for simultaneous characterization of isotype and binding region of human anti-tocilizumab antibodies with control by surrogate standards. Analytical Biochemistry. 390(2). 189–196. 33 indexed citations

Schleypen, Julia, Nicole Baur, Robert Kammerer, et al.. (2006). Cytotoxic Markers and Frequency Predict Functional Capacity of Natural Killer Cells Infiltrating Renal Cell Carcinoma. Clinical Cancer Research. 12(3). 718–725. 112 indexed citations

Rohrmann, K., Julia Schleypen, C. Adam, A Hofstetter, & Michael Siebels. (2004). Komplette Remission beim pulmonal metastasierten Nierenzellkarzinom durch Inhalationstherapie mit Interleukin-2 nach erfolgloser systemischer Immunchemotherapie. Der Urologe. 43(10). 1271–1274. 3 indexed citations

Kammerer, Robert, Rainer Riesenberg, Christoph Weiler, et al.. (2004). The tumour suppressor gene CEACAM1 is completely but reversibly downregulated in renal cell carcinoma. The Journal of Pathology. 204(3). 258–267. 42 indexed citations

Schendel, Dolores J., Christine S. Falk, Bernhard Frankenberger, et al.. (2004). The cellular and molecular basis of natural antitumor immunity in renal cell carcinoma patients. Der Urologe. 43(S3). 133–135. 1 indexed citations

10.

Schleypen, Julia, et al.. (2003). Renal cell carcinoma‐infiltrating natural killer cells express differential repertoires of activating and inhibitory receptors and are inhibited by specific HLA class I allotypes. International Journal of Cancer. 106(6). 905–912. 97 indexed citations

11.

Stover, Cordula, Julia Schleypen, J. Grønlund, et al.. (2000). Assignment<footref rid="foot01"><sup>1</sup></footref> of CD163B, the gene encoding M160, a novel scavenger receptor, to human chromosome 12p13.3 by in situ hybridization and somatic cell hybrid analysis. Cytogenetic and Genome Research. 90(3-4). 246–247. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact